Shares of SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) surged in pre-market trading after the company reported the FDA approval of OGSIVEO (nirogacestat) as the first and only treatment for adults with desmoid tumors.
SpringWorks Therapeutics shares rose 14.4% to $23.77 in pre-market trading
Here are some other stocks moving in pre-market trading.
Gainers
- SaverOne 2014 Ltd (NASDAQ: SVRE) shares rose 74.8% to $0.7389 in pre-market trading. SaverOne announced withdrawal of proposed public offering due to market conditions.
- ESGL Holdings Limited (NASDAQ: ESGL) shares rose 54.3% to $1.38 in pre-market trading after the company disclosed a multi-year contract renewal with Singapore Refining Company Private Limited.
- Heart Test Laboratories, Inc. (NASDAQ: HSCS) rose 27.5% to $0.2735 in pre-market trading. Heart Test Laboratories 13G filing showed Icahn School of Medicine at Mount Sinai ("ISMMS") EIN 13-6171197 reported a 9.9% stake in the company, as of Nov. 16, 2023.
- RedHill Biopharma Ltd. (NASDAQ: RDHL) shares surged 21% to $1.21 in pre-market trading. Redhill Biopharma shares jumped 217% ...